Impact of discordant revised versus molecular international prognostic scoring system risk in myelodysplastic syndrome.

Saved in:
Bibliographic Details
Title: Impact of discordant revised versus molecular international prognostic scoring system risk in myelodysplastic syndrome.
Authors: Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. abazinet@mdanderson.org., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Bouligny I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Swaminathan M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Jen WY; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Popat U; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Short N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Source: Leukemia [Leukemia] 2025 Nov; Vol. 39 (11), pp. 2820-2824. Date of Electronic Publication: 2025 Sep 05.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-025-02760-x